- Details
- Written by IVN
- Category: Health News
Washington, DC - Based on sound science and a comprehensive review, the U.S. Food and Drug Administration is taking several important steps regarding food from genetically engineered (GE) plants and animals, including the first approval for a genetically engineered animal intended for food, AquAdvantage Salmon. The agency is also issuing two guidances for manufacturers who wish to voluntarily label their products as containing ingredients from GE or non-GE sources: a draft guidance on labeling foods derived from Atlantic salmon, and a final guidance on foods derived from GE plants.
- Details
- Written by IVN
- Category: Health News
Washington, DC - The U.S. Food and Drug Administration, in partnership with other government agencies, announced the results of a yearlong sweep of dietary supplements to identify potentially unsafe or tainted supplements. The sweep resulted in civil injunctions and criminal actions against 117 various manufacturers and/or distributors of dietary supplements and tainted products falsely marketed as dietary supplements. Among the cases announced today is a criminal case charging USPlabs LLC and several of its corporate officers. USPlabs was known for its widely popular workout and weight loss supplements, which it sold under names such as Jack3d and OxyElite Pro.
- Details
- Written by IVN
- Category: Health News
Washington, DC - A survey of American adults revealed that drug use disorder is common, co-occurs with a range of mental health disorders and often goes untreated. The study, funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health, found that about 4 percent of Americans met the criteria for drug use disorder in the past year and about 10 percent have had drug use disorder at some time in their lives.
- Details
- Written by Stephanie Desmon
- Category: Health News
Baltimore, Maryland - Researchers from the Johns Hopkins Bloomberg School of Public Health have found a link between higher levels of a specific kind of air pollution in major urban areas and an increase in cardiovascular-related hospitalizations such as for heart attacks in people 65 and older.
- Details
- Written by IVN
- Category: Health News
Washington, DC - A clinical trial funded by the National Institutes of Health has found that the drug ranibizumab (Lucentis) is highly effective in treating proliferative diabetic retinopathy. The trial, conducted by the Diabetic Retinopathy Clinical Research Network (DRCR.net) compared Lucentis with a type of laser therapy called panretinal or scatter photocoagulation, which has remained the gold standard for proliferative diabetic retinopathy since the mid-1970s. The findings demonstrate the first major therapy advance in nearly 40 years.
- Details
- Written by Sheryl M. Ness, R.N.
- Category: Health News
Rochester, Minnesota - It's that time of year again. Thanksgiving and the start of the busy holiday season are here. As you reflect on the past year as a survivor, whatever your experience has been, take time to recognize the strength that you have inside of you, the family members who have been by your side and the friends who did not let cancer get between you.
Page 187 of 374
